GCP
LONA

GSA Capital Partners’s LeonaBio Inc LONA Stock Holding History

GSA Capital Partners’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,823
Closed -$25K – 1734
2025
Q1 		$25K Sell
8,823
-20,833
-70% -$92.3K ﹤0.01% 1576
2024
Q4 		$174K Sell
29,656
-10,055
-25% -$56.7K 0.01% 1443
2024
Q3 		$177K Buy
39,711
+35,779
+910% +$839K 0.01% 1434
2024
Q2 		$104K Sell
3,932
-13,691
-78% -$323K 0.01% 1527
2024
Q1 		$483K Sell
17,623
-12,462
-41% -$395K 0.04% 906
2023
Q4 		$731K Buy
30,085
+380
+1% +$6.74K 0.06% 565
2023
Q3 		$600K Sell
29,705
-4,938
-14% -$126K 0.05% 680
2023
Q2 		$1.02M Sell
34,643
-1,381
-4% -$39.3K 0.1% 301
2023
Q1 		$901K Buy
36,024
+8,925
+33% +$287K 0.09% 371
2022
Q4 		$859K Buy
27,099
+10,147
+60% +$320K 0.11% 281
2022
Q3 		$503K Buy
+16,952
New +$585K 0.07% 566

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return

GSA Capital Partners's LONA Position: Q2 2025 in Review

GSA Capital Partners sold out of LeonaBio Inc (LONA) in Q2 2025, closing a stake of 8,823 shares — an estimated $25K sold.

GSA Capital Partners first reported a position in LONA in Q3 2022 and held it in 11 quarters. The position peaked at $1.02M in Q2 2023. 50 funds tracked by Wall St. Rank hold LONA as of Q2 2025.

  • GSA Capital Partners reported no remaining LeonaBio Inc position as of Q2 2025 after selling out during the quarter.
  • GSA Capital Partners sold 8,823 LeonaBio Inc shares in Q2 2025, an estimated $25K.
  • GSA Capital Partners first reported a position in LeonaBio Inc in Q3 2022 and held it in 11 quarters.
  • GSA Capital Partners's LeonaBio Inc position peaked at $1.02M in Q2 2023.
  • 50 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2025.

Based on GSA Capital Partners's 13F filing for Q2 2025, filed 22 Jul 2025.